BACKGROUND: There is compelling evidence of a genetic foundation of patient-reported quality of life (QOL). Given the rapid development of substantial scientific advances in this area of research, the current paper updates and extends reviews published in 2010. OBJECTIVES: The objective was to provide an updated overview of the biological pathways, candidate genes, and molecular markers involved in fatigue, pain, negative (depressed mood) and positive (well-being/happiness) emotional functioning, social functioning, and overall QOL. METHODS: We followed a purposeful search algorithm of existing literature to capture empirical papers investigating the relationship between biological pathways and molecular markers and the identified QOL domains. RESULTS: Multiple major pathways are involved in each QOL domain. The inflammatory pathway has the strongest evidence as a controlling mechanism underlying fatigue. Inflammation and neurotransmission are key processes involved in pain perception, and the catechol-O-methyltransferase (COMT) gene is associated with multiple sorts of pain. The neurotransmitter and neuroplasticity theories have the strongest evidence for their relationship with depression. Oxytocin-related genes and genes involved in the serotonergic and dopaminergic pathways play a role in social functioning. Inflammatory pathways, via cytokines, also play an important role in overall QOL. CONCLUSIONS: Whereas the current findings need future experiments and replication efforts, they will provide researchers supportive background information when embarking on studies relating candidate genes and/or molecular markers to QOL domains. The ultimate goal of this area of research is to enhance patients' QOL.
BACKGROUND: There is compelling evidence of a genetic foundation of patient-reported quality of life (QOL). Given the rapid development of substantial scientific advances in this area of research, the current paper updates and extends reviews published in 2010. OBJECTIVES: The objective was to provide an updated overview of the biological pathways, candidate genes, and molecular markers involved in fatigue, pain, negative (depressed mood) and positive (well-being/happiness) emotional functioning, social functioning, and overall QOL. METHODS: We followed a purposeful search algorithm of existing literature to capture empirical papers investigating the relationship between biological pathways and molecular markers and the identified QOL domains. RESULTS: Multiple major pathways are involved in each QOL domain. The inflammatory pathway has the strongest evidence as a controlling mechanism underlying fatigue. Inflammation and neurotransmission are key processes involved in pain perception, and the catechol-O-methyltransferase (COMT) gene is associated with multiple sorts of pain. The neurotransmitter and neuroplasticity theories have the strongest evidence for their relationship with depression. Oxytocin-related genes and genes involved in the serotonergic and dopaminergic pathways play a role in social functioning. Inflammatory pathways, via cytokines, also play an important role in overall QOL. CONCLUSIONS: Whereas the current findings need future experiments and replication efforts, they will provide researchers supportive background information when embarking on studies relating candidate genes and/or molecular markers to QOL domains. The ultimate goal of this area of research is to enhance patients' QOL.
Authors: Juan R Ordoñana; Meike Bartels; Dorret I Boomsma; David Cella; Miriam Mosing; Joao R Oliveira; Donald L Patrick; Ruut Veenhoven; Gert G Wagner; Mirjam A G Sprangers Journal: Qual Life Res Date: 2012-10-10 Impact factor: 4.147
Authors: Katharina Schroecksnadel; Michael Fiegl; Karin Prassl; Christiana Winkler; Hubert A Denz; Dietmar Fuchs Journal: J Cancer Res Clin Oncol Date: 2007-03-14 Impact factor: 4.553
Authors: Mirjam A G Sprangers; Jeff A Sloan; Andrea Barsevick; Cynthia Chauhan; Amylou C Dueck; Hein Raat; Quiling Shi; Cornelis J F Van Noorden Journal: Qual Life Res Date: 2010-10-14 Impact factor: 4.147
Authors: A A Brown; J Jensen; Y S Nikolova; S Djurovic; I Agartz; A Server; R E Ferrell; S B Manuck; M Mattingsdal; I Melle; A R Hariri; A Frigessi; O A Andreassen Journal: Transl Psychiatry Date: 2012-07-24 Impact factor: 6.222
Authors: S I Shyn; J Shi; J B Kraft; J B Potash; J A Knowles; M M Weissman; H A Garriock; J S Yokoyama; P J McGrath; E J Peters; W A Scheftner; W Coryell; W B Lawson; D Jancic; P V Gejman; A R Sanders; P Holmans; S L Slager; D F Levinson; S P Hamilton Journal: Mol Psychiatry Date: 2009-12-29 Impact factor: 15.992
Authors: Marjolein J Peters; Linda Broer; Hanneke L D M Willemen; Gudny Eiriksdottir; Lynne J Hocking; Kate L Holliday; Michael A Horan; Ingrid Meulenbelt; Tuhina Neogi; Maria Popham; Carsten O Schmidt; Anushka Soni; Ana M Valdes; Najaf Amin; Elaine M Dennison; Niels Eijkelkamp; Tamara B Harris; Deborah J Hart; Albert Hofman; Frank J P M Huygen; Karen A Jameson; Gareth T Jones; Lenore J Launer; Hanneke J M Kerkhof; Marjolein de Kruijf; John McBeth; Margreet Kloppenburg; William E Ollier; Ben Oostra; Antony Payton; Fernando Rivadeneira; Blair H Smith; Albert V Smith; Lisette Stolk; Alexander Teumer; Wendy Thomson; André G Uitterlinden; Ke Wang; Sophie H van Wingerden; Nigel K Arden; Cyrus Cooper; David Felson; Vilmundur Gudnason; Gary J Macfarlane; Neil Pendleton; P Eline Slagboom; Tim D Spector; Henry Völzke; Annemieke Kavelaars; Cornelia M van Duijn; Frances M K Williams; Joyce B J van Meurs Journal: Ann Rheum Dis Date: 2012-09-06 Impact factor: 19.103
Authors: Kimberly E Alexander; Suzanne Chambers; Amanda B Spurdle; Jyotsna Batra; Felicity Lose; Tracy A O'Mara; Robert A Gardiner; Joanne F Aitken; Judith A Clements; Mary-Anne Kedda; Monika Janda Journal: Qual Life Res Date: 2015-02-28 Impact factor: 4.147
Authors: Kimberly E Alexander; Bruce A Cooper; Steven M Paul; Patsy Yates; Bradley E Aouizerat; Christine Miaskowski Journal: Qual Life Res Date: 2016-05-09 Impact factor: 4.147
Authors: Diego Alves Vieira; Luciana Rodrigues da Cunha; Cliviany Borges da Silva; Maria Thereza Bastos Almeida; Adriana Dias Gomes; César Lúcio Lopes de Faria; Rosângela Teixeira; Fernando Silva Neves; Gifone Aguiar Rocha; Fabrício Freire de Melo; Dulciene Maria de Magalhães Queiroz; Luciana Diniz Silva Journal: Qual Life Res Date: 2019-02-07 Impact factor: 4.147
Authors: Martine Extermann; Christiaan Leeuwenburgh; Laila Samiian; Marina Sehovic; Jinze Xu; Christopher Cubitt; Paul B Jacobsen; Marco Pahor; Stephen R Grobmyer; Todd M Manini Journal: J Geriatr Oncol Date: 2016-10-13 Impact factor: 3.599
Authors: Kimberly Alexander; Yvette P Conley; Jon D Levine; Bruce A Cooper; Steven M Paul; Judy Mastick; Claudia West; Christine Miaskowski Journal: J Pain Symptom Manage Date: 2017-09-23 Impact factor: 3.612
Authors: Melissa S Y Thong; Mirjam A G Sprangers; Jeff A Sloan; Donald L Patrick; Ping Yang; Cornelis J F van Noorden Journal: Qual Life Res Date: 2014-11-12 Impact factor: 4.147